MF
CERE

Magnetar Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Magnetar Financial’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,014,239
Closed -$41.5M – 748
2024
Q2 		$41.5M Sell
1,014,239
-4,189
-0.4% -$174K 0.86% 42
2024
Q1 		$43M Hold
1,018,428
– – 0.96% 33
2023
Q4 		$43.2M Buy
+1,018,428
New +$29.3M 1.1% 26

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Magnetar Financial's CERE Position: Q3 2024 in Review

Magnetar Financial sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 1,014,239 shares — an estimated $41.5M sold.

Magnetar Financial first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $43.2M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Magnetar Financial reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Magnetar Financial sold 1,014,239 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $41.5M.
  • Magnetar Financial first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Magnetar Financial's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $43.2M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Magnetar Financial's 13F filing for Q3 2024, filed 13 Nov 2024.